31 August 2024
Latham & Watkins Advises Arcus Biosciences in US$250 Million Growth Facility
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Haim Zaltzman Lead | Latham & Watkins LLP | Partner | transactional | Not stated |
| Mark Roeder Lead | Latham & Watkins LLP | Partner | transactional | Not stated |
| Trevor Church | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Erin Cusenbary | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Tyler Davis | Latham & Watkins LLP | Associate | Not stated | Not stated |
| John Williams | Latham & Watkins LLP | Partner | corporate | Not stated |
| Jekkie Kim | Latham & Watkins LLP | Partner | intellectual property | Not stated |
| Mizuna Sekine | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA/regulatory | Not stated |
| Reza Mojtabaee-Zamani | Latham & Watkins LLP | Partner | transaction | Not stated |
| Kevin Zhang | Latham & Watkins LLP | Associate | transaction | Not stated |
10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 250m (US$250 million)
- What the figure measures
- Facility amount
- Client
- Arcus Biosciences, Inc.Borrower
- Counterparties
- Hercules Capital, Inc. (Lenders)